Titre Personalized Targeted Therapy in Refractory or Relapsed Cancer in Childhood(TRICEPS Study)
Protocole ID TRICEPS
ClinicalTrials.gov ID NCT02242552
Type(s) de cancer Pédiatrique divers
Phase
Institution CENTRE UNIVERSITAIRE DE SANTE MCGILL
   HOPITAL DE MONTREAL POUR ENFANTS
      1001 boul. Décarie , Montréal, QC, H4A 3J1
Ville Montréal
Investigateur(trice) principal(e) Dr David Mitchell
Coordonnateur(trice) Emma Anillo
 514-412-4400 poste 23807
Statut Actif en recrutement
Critètes d'éligibilité
  • 21 year-old or less
  • Poor prognosis biopsy-proven cancer of any type :
  • Cancer (at initial diagnosis) known to be refractory to treatment
  • Or cancer refractory to treatment
  • Or relapsed cancer
  • Written informed consent by patient, parents, or the legal guardians
Critètes d'exclusion
  • Estimated life expectancy of less than 3 months.